The Binding Site
Investment date: September 2011
Exit date: January 2023
Partners: Management, Nordic Capital
The Binding Site is a UK-based international diagnostics business specialising in the research, development and manufacture of innovative, high-quality tests used for the detection of certain cancers and other serious disorders. Originally formed from a spin-out from Birmingham University, the company has over 25 years experience in producing highly sensitive and highly specific tests. The Binding Site and its associated product names have achieved strong brand recognition with an excellent reputation for quality, reliability and service. The company operates from a research and manufacturing facility in the UK and markets its products to ~95 countries globally through local sales subsidiaries and a network of distributors. The Binding Site is headquartered in Birmingham, UK.